SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
哈哈
Lv1
16 积分
2023-10-28 加入
最近求助
最近应助
互助留言
Protein O-GlcNAcylation and hexokinase mitochondrial dissociation drive heart failure with preserved ejection fraction
2天前
已完结
Organization of a functional glycolytic metabolon on mitochondria for metabolic efficiency
1个月前
已完结
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy
3个月前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
3个月前
已完结
Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec-9 and Suppresses Macrophage Phagocytosis
3个月前
已完结
The effect of immunotherapy PD-1 blockade on acute bone cancer pain: Insights from transcriptomic and microbiomic profiling
6个月前
已完结
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma
1年前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
1年前
已完结
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury
1年前
已完结
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
没有进行任何应助
感谢
1个月前
感谢
3个月前
感谢
3个月前
感谢
3个月前
感谢
6个月前
谢谢
1年前
谢谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论